[Clinical pharmacology of the new Soviet anti-inflammatory preparation ortofen].

Comparative pharmacokinetic and pharmacodynamic studies on ortophen, a new Soviet antiinflammatory drug, and voltaren (Ciba-Geigy, Switzerland) were carried out in 73 patients with rheumatoid arthritis. Pharmacokinetics of both drugs was studied in 19 patients (9 patients were given voltaren, 10--ortophen). Pharmacokinetic difference was statistically indistinguishable. The comparison of the principal routine subjective and objective pharmacodynamic indices revealed no significant difference between ortophen and voltaren action. The new drug was shown to possess a high analgetic and antiinflammatory activity.
AuthorsV G Kukes, V V Murashko, M V Iagunina, V I Volchenok, V I Pokryshkin
JournalTerapevticheskiĭ arkhiv (Ter Arkh) Vol. 60 Issue 3 Pg. 105-9 ( 1988) ISSN: 0040-3660 [Print] USSR
Vernacular TitleKlinicheskaia farmakologiia novogo otechesvennogo protivovospalitel'nogo preparata ortofena.
PMID3388258 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Diclofenac
  • Arthritis, Rheumatoid (blood, drug therapy)
  • Blood Sedimentation
  • Diclofenac (pharmacokinetics, pharmacology, therapeutic use)
  • Drug Evaluation
  • Drug Tolerance
  • Half-Life
  • Humans
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: